Chemistry and immunoassay testing - cost per reportable result (cprr) - continued contract for W81K0024F0153
Ended Awarded Last action
- Contract number
- W81K0026FA053
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $397,692
Award facts
- Contract value 100% obligated
- $397,692.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $397,692.13 delivery order to Roche Diagnostics Corporation for continued chemistry and immunoassay testing services on a cost-per-reportable-result (CPRR) basis. This child delivery order, designated as W81K0024F0153, is scheduled for completion by April 4, 2026, and will be performed at Fort Sam Houston in San Antonio, Texas. The contract employs firm fixed-price pricing without set-aside designation, reflecting open competition. Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana, is a foreign-owned manufacturer specializing in in vitro diagnostic technologies, laboratory instruments, and reagents that support the Department of Defense's medical testing requirements.
This delivery order represents a continuation of Roche's extensive partnership with the Defense Health Agency, which maintains multiple indefinite delivery contracts and blanket purchase agreements totaling tens of millions of dollars for diagnostic equipment and testing services across military healthcare facilities. The CPRR pricing model aligns with the Defense Health Agency's laboratory automation initiatives and supports clinical operations at major military medical centers like Brooke Army Medical Center. Roche's federal contracting portfolio demonstrates sustained demand for its diagnostic capabilities, with active contracts extending through 2030 across the Department of Veterans Affairs and various Department of Defense healthcare installations, positioning the company as a primary supplier of advanced diagnostic solutions to the military healthcare system.
Quick answers
Who was awarded contract W81K0026FA053?
W81K0026FA053 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on February 4, 2026.
How much is contract W81K0026FA053 worth?
The government has obligated $397,692 on W81K0026FA053.
Which agency awarded contract W81K0026FA053?
Medical Command (Department of the Army) awarded W81K0026FA053, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0026FA053 an order under another contract?
Yes. W81K0026FA053 is a delivery order under W81K0023D0004, an indefinite delivery contract.
Was contract W81K0026FA053 competed?
The extent of competition for W81K0026FA053 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award